Miriam Freimer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Miriam Freimer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Miriam Freimer Today - Breaking & Trending Today

Sustained Benefit for Newly Approved Myasthenia Gravis Drug

Published: November 15, 2023

Early responders to zilucoplan, the newly approved medication for myasthenia gravis have sustained benefit for up to 60 weeks, new analyses show.

Source: medscape.com

Related Topics:

United StatesMiriam FreimerDepartment Of NeurologyDrug AdministrationOhio State UniversityAmerican Association Of Neuromuscular Electrodiagnostic MedicineDivision Of Neuromuscular DisordersMg Foundation Of AmericaMedscape MedicalNeuromuscular Electrodiagnostic MedicineMedscape Medical NewsDaily LivingNeuromuscular DisordersMyasthenia Gravis ClinicMyasthenia GravisMuscular AtrophyUscular AtrophiesClinical ResearchClinical TrialsLinical StudiesHealthcare And Medical TechnologyEalth And Medical TechEalth And Med TechEalth And Medical TechnologyMeningococcal Infection